Novare Capital Management LLC Bristol Myers Squibb CO Transaction History
Novare Capital Management LLC
- $1.1 Billion
- Q1 2024
A detailed history of Novare Capital Management LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Novare Capital Management LLC holds 5,830 shares of BMY stock, worth $235,823. This represents 0.03% of its overall portfolio holdings.
Number of Shares
5,830
Previous 3,980
46.48%
Holding current value
$235,823
Previous $204,000
54.9%
% of portfolio
0.03%
Previous 0.02%
Shares
26 transactions
Others Institutions Holding BMY
# of Institutions
2,553Shares Held
1.49BCall Options Held
25.9MPut Options Held
20M-
Vanguard Group Inc Valley Forge, PA186MShares$7.53 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY163MShares$6.58 Billion0.21% of portfolio
-
State Street Corp Boston, MA91.6MShares$3.7 Billion0.23% of portfolio
-
Jpmorgan Chase & CO New York, NY88.8MShares$3.59 Billion0.44% of portfolio
-
Capital International Investors Los Angeles, CA70.2MShares$2.84 Billion0.79% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $86B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...